Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06125704 · ClinicalTrials.gov registry record · NA

Time to Move in Pregnancy Hyperglycemia

A NA study of Physical Activity and Exercise, sponsored by The University of Tennessee, Knoxville.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT06125704: Recruiting NA study of Physical Activity and Exercise, sponsored by The University of Tennessee, Knoxville.

NCT06125704 is a NA study of Physical Activity and Exercise that is actively recruiting participants, run by The University of Tennessee, Knoxville. The registered enrollment target is 36 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06125704, a NA study of Physical Activity and Exercise, is actively recruiting participants, sponsored by The University of Tennessee, Knoxville.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

This randomized controlled crossover trial of 36 pregnant individuals with gestational diabetes (GDM) or gestational glucose intolerance (GGI) will: 1. Determine the effects of physical activity (PA) timing, specifically 30 minutes of moderate intensity walking or stepping in the morning (between 5am-9am, within 30-40 minutes of starting breakfast), versus late afternoon/evening (between 4pm-8pm, within 30-40 minutes of dinner) on glucose across the 24-hour cycle. 2. Explore the potential effects of the timing of PA on sleep and mood state.

Primary Outcome

Glucose outcome measures include: 24-hour glucose and coefficient of variation, daytime glucose, nighttime glucose, pre-breakfast area under the glucose curve (AUC; calculated for the 120 minutes prior to the start of breakfast), and all post-meal AUCs (calculated for the 120 minutes after the start of the breakfast, lunch and dinner).

Conditions Studied

Physical Activity Exercise Hyperglycemia Glucose Intolerance Circadian Rhythm GDM

Interventions

  • BEHAVIORAL Moderate intensity walking or stepping

Study Locations (1)

Tennessee

  • The University of Tennessee Medical Center - Knoxville

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-12-06
Est. Completion 2025-12
Phase NA
The University of Tennessee, Knoxville

81 total trials

What NCT06125704 shows while recruiting

NCT06125704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (90% lower).

The record links to 6 conditions, with Physical Activity appearing as the primary indexed condition, and to 1 intervention - of which Moderate intensity walking or stepping is the first listed.

NCT06125704 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT06125704 about?

NCT06125704 is a clinical study titled "Time to Move in Pregnancy Hyperglycemia". This randomized controlled crossover trial of 36 pregnant individuals with gestational diabetes (GDM) or gestational glucose intolerance (GGI) will: 1. Determine the effects of physical activity (PA) timing, specifically 30 minutes of moderate intensity walking or stepping in the morning (between 5...

What is the current status of trial NCT06125704?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-12-06. Estimated completion is 2025-12.

What conditions does trial NCT06125704 study?

This clinical trial studies the following conditions: Physical Activity, Exercise, Hyperglycemia, Glucose Intolerance, Circadian Rhythm.

What interventions are being tested in trial NCT06125704?

The interventions under investigation include: Moderate intensity walking or stepping (BEHAVIORAL).

Who is sponsoring clinical trial NCT06125704?

This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06125704 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Physical Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06125704's enrollment target sits among peer trials

36 110th of 131 higher than 22 of 131 other Physical Activity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06125704

Source: ClinicalTrials.gov NCT06125704, the US trial registry maintained by the National Library of Medicine. NCT06125704 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.